Responses
Clinical and epidemiological research
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine
Compose a Response to This Article
Other responses
No responses have been published for this article.